[Re-entry mechanism of ventricular tachycardias in inhomogenic repolarization. With special reference to Jervell-Lange-Nielsen syndrome and similar states and their therapy].
D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001161:Arteriosclerosis / Q000150:complications; D002301:Cardiac Glycosides / Q000494:pharmacology; D002493:Central Nervous System Diseases / Q000150:complications; D003327:Coronary Disease / Q000150:complications; D003638:Deafness / Q000151:congenital*; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System / Q000503:physiopathology; D006331:Heart Diseases / Q000503:physiopathology*; D006352:Heart Ventricles; D006801:Humans; D007008:Hypokalemia / Q000150:complications; D000860:Hypoxia / Q000150:complications; D011802:Quinidine / Q000506:poisoning; D013575:Syncope / Q000503:physiopathology*; D013577:Syndrome; D013610:Tachycardia / Q000503:physiopathology
D002301:Cardiac Glycosides; D011802:Quinidine
Re-entry-Mechanismus ventrikulärer Tachykardien bei inhomogener Repolarisation. Unter besonderer Berücksichtigung des Jervell-Lange-Nielsen-Syndroms und ähnlicher Zustände und inrer Therapie